eloquesthealthcare.comEloquest Healthcare, Inc. – We Care About the Care You Deliver

1-877-433-7626 780 West Eight Mile Road Ferndale, MI 48220 Linkedin page opens in new window Facebook page opens in new window YouTube page opens in new window X-Twitter page opens in new window Eloquest Healthcare, Inc. We Care About the Care You Deliver HomeNews & Events Community Impact Patient Safety Movement Careers Solutions Minimize Risk of CLABSI Mastisol®Liquid Adhesive SecurAcath Minimize Risk of Skin Tears Detachol® Adhesive Remover Reduce Dermal Pain LMX4® Topical Anesthetic Cream Our Products Mastisol® Liquid Adhesive Mastisol® Clinical Evidence & Resources Testimonials Detachol® Adhesive Remover Detachol® Clinical Evidence & Resources Testimonials SecurAcath® SecurAcath® Clinical Evidence SecurAcath® Clinician Resources Instructions for Use Testimonials LMX4® Topical Anesthetic Cream LMX4® Clinical Evidence & Resources Resources Clinical Evidence & Resources Mastisol® Liquid Adhesive SecurAcath® Detachol® Adhesive Remover LMX4® Topical Anesthetic Cream Testimonials Educational Webinars Videos FAQ Blog Contact Partnership Request Trial Request Report Complaint Patient Assistance Store Search: HomeNews & Events Community Impact Patient Safety Movement Careers Solutions Minimize Risk of CLABSI Mastisol®Liquid Adhesive SecurAcath Minimize Risk of Skin Tears Detachol® Adhesive Remover Reduce Dermal Pain LMX4® Topical Anesthetic Cream Our Products Mastisol® Liquid Adhesive Mastisol® Clinical Evidence & Resources Testimonials Detachol® Adhesive Remover Detachol® Clinical Evidence & Resources Testimonials SecurAcath® SecurAcath® Clinical Evidence SecurAcath® Clinician Resources Instructions for Use Testimonials LMX4® Topical Anesthetic Cream LMX4® Clinical Evidence & Resources Resources Clinical Evidence & Resources Mastisol® Liquid Adhesive SecurAcath® Detachol® Adhesive Remover LMX4® Topical Anesthetic Cream Testimonials Educational Webinars Videos FAQ Blog Contact Partnership Request Trial Request Report Complaint Patient Assistance Store About Eloquest Healthcare ­­­­ Eloquest Healthcare, Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc. that is focused specifically on serving hospitals, their healthcare practitioners, and patients. Eloquest Healthcare helps deliver safer, more compassionate care by providing intuitive, cost-effective solutions that aid in the prevention of hospital acquired infections. Learn More About Eloquest Our Products Why Partner With Us? Better Clinical Outcomes Reduced risk of central line-associated bloodstream infections (CLABSI), post-op wound contamination, and skin injuries. Higher Quality Support Educational resources, knowledgeable field representatives, home office support. Lower Cost of Care Reduced material cost from waste and lower payment penalties from improvement in care quality. 3 Main Reasons to Choose Eloquest Better Clinical Outcomes We strive for better clinical outcomes. Eloquest Healthcare works towards reduced risk of central line-associated bloodstream infections (CLABSI), post-op wound contamination, and skin injuries. Higher Quality Support You’re not alone. Eloquest Healthcare takes pride in providing higher quality support to you and your facility. Educational resources, knowledgeable field representatives, home office support are just a few of the things we provide for you. Lower Cost of Care Eloquest Healthcare aims to lower your facility’s cost of care through reduced material cost from waste and lower payment penalties from improvement in care quality. Recent News & Events Current Month Vascular Access Talk: Keep It Simple Specialist Keep It Simple Specialist: One PICC, One Securement Device, Until End of Need At the AVA 2023 Scientific Meeting during the Vascular Access Talk sessions, Michelle (Mickey) Hawes, RN, DNP, CRNI, VA-BC, ACRP-CP followed-up her 2022 securement presentation and dove into the latest peer-reviewed data on SecurAcath. Affectionately referred to as the Clatterbridge Study, because… Mickey Hawes Clatterbridge Study Interview Mickey Hawes Clatterbridge Study Interview In this 3-minute interview, Mickey Hawes, RN, DNP, CRNI, VA-BC, ACRP-CP discusses a 2023 article published in the Journal of Vascular Access, A retrospective study of subcutaneous anchor securement systems in oncology patients”, also referred to as The Clatterbridge Study”, and what it means for patients with a peripherally-inserted central… Unlocking the Power of Vascular Access Teams: A Strategy to Reduce Catheter-Related Bloodstream Infections Unlocking the Power of Vascular Access Teams: A Strategy to Reduce Catheter-Related Bloodstream Infections The reduction and ultimate prevention of catheter-related bloodstream infections (CRBSIs) is a key step to improving overall inpatient outcomes. And specially trained vascular access clinicians are key to making that reality possible. Bloodstream infections are a life-threatening challenge to the patient… 3 Questions with Cheri Gillette, RN, VA-BC, CNPI 3 Questions with Cheri Gillette, RN, VA-BC, CNPI 3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Cheri Gillette, RN,… 3 Questions with Molly Judge, BSN, RN, CRNI, VA-BC 3 Questions with Molly Judge, BSN, RN, CRNI, VA-BC 3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Molly Judge,… AVA 2023 Top Ten Poster: Mastisol’s Mark on Dressing Integrity AVA 2023 Top Ten Poster: Mastisol’s Mark on Dressing Integrity Dressing adherence took center stage at the Association of Vascular Access Annual Scientific Meeting (AVA 2023, Portland, OR; Oct. 14-17, 2023). A poster by Logan Doyle, BSN, RN, VA-BC and Christina Greene, BSN, RN, VA-BC described dramatic improvements in dressing adherence after initiation of use… 3 Questions with Kayla Jordan, BSN, RN, VA-BC 3 Questions with Kayla Jordan, BSN, RN, VA-BC, Manager, Vascular Access Services at HCA Healthcare Tristar Division 3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is… 2023 Year in Review As 2023 ends, we would like to thank you for reading the Eloquest Healthcare Blog! We hope you have found our posts during the last 12 months to be both informative and impactful to your professional career. Here are some of the past year’s most liked posts that we invite you to visit… In ‘Hospital… Getting Unstuck: How Detachol Simplifies Adhesive Removal Getting Unstuck: How Detachol Simplifies Adhesive Removal For most patients, medical adhesive removal is a necessary but unpleasant part of the healthcare journey. Strong adhesives are essential for maintaining dressing integrity – particularly for vascular access securement – but they can pose significant challenges when it’s time to remove the dressing. It can involve painful… Study Shows Improved LVAD Dressing Integrity for Heart Failure Patients with Gum Mastic Liquid Adhesive Study Proves Gum Mastic Liquid Adhesive Enhances LVAD Dressing Integrity Heart failure is a growing public health issue, and for those with advanced or end-stage heart failure, left ventricular assist devices (LVADs) are a true technological lifeline. Alongside heart transplants, LVADs have become the standard of care for patients with advanced heart failure, serving as… Eloquest Healthcare®, Detachol®, LMX4®, Mastisol® and their logos are registered trademarks of Ferndale IP, Inc. © Copyright 2023 Eloquest...